User profiles for Mary F. Davis
Mary DavisBrigham Young Universityq Verified email at byu.edu Cited by 1508 |
[PDF][PDF] Low-frequency and rare-coding variation contributes to multiple sclerosis risk
Multiple sclerosis is a complex neurological disease, with ∼20% of risk heritability attributable
to common genetic variants, including >230 identified by genome-wide association …
to common genetic variants, including >230 identified by genome-wide association …
Automated extraction of clinical traits of multiple sclerosis in electronic medical records
Objectives The clinical course of multiple sclerosis (MS) is highly variable, and research
data collection is costly and time consuming. We evaluated natural language processing …
data collection is costly and time consuming. We evaluated natural language processing …
Worksite health promotion in Colorado.
MF Davis, K Rosenberg, DC Iverson… - Public Health …, 1984 - ncbi.nlm.nih.gov
T HE WORKSITE HAS BECOME the target of numerous groups seeking to improve the health
of the adult population. In 1979, the Public Health Service's Office of Health Information …
of the adult population. In 1979, the Public Health Service's Office of Health Information …
The intelligent use and clinical benefits of electronic medical records in multiple sclerosis
MF Davis, JL Haines - Expert review of clinical immunology, 2015 - Taylor & Francis
Electronic medical records (EMRs) are being quickly adopted in clinics around the world.
This advancement can greatly enhance the clinical care of patients with multiple sclerosis (MS) …
This advancement can greatly enhance the clinical care of patients with multiple sclerosis (MS) …
Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells.
M Ticchioni, M Deckert, F Mary, G Bernard… - … (Baltimore, Md.: 1950 …, 1997 - journals.aai.org
IAP is a glycoprotein functionally and physically associated with some integrins, ie, the
leukocyte response integrin and the beta3 integrin chain on placenta, platelets, and …
leukocyte response integrin and the beta3 integrin chain on placenta, platelets, and …
Influence of dietary substances on intestinal drug metabolism and transport
CS Won, NH Oberlies, MF Paine - Current drug metabolism, 2010 - ingentaconnect.com
Successful delivery of promising new chemical entities via the oral route is rife with
challenges, some of which cannot be explained or foreseen during drug development. Further …
challenges, some of which cannot be explained or foreseen during drug development. Further …
[HTML][HTML] Is lost lean mass from intentional weight loss recovered during weight regain in postmenopausal women?
KM Beavers, MF Lyles, CC Davis, X Wang… - The American journal of …, 2011 - Elsevier
Background: Despite the well-known recidivism of obesity, surprisingly little is known about
the composition of body weight during weight regain. Objective: The objective of this study …
the composition of body weight during weight regain. Objective: The objective of this study …
[PDF][PDF] Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks
Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin
type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect …
type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect …
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro
Y Dai, MF Hebert, N Isoherranen, CL Davis… - Drug metabolism and …, 2006 - ASPET
Previous investigations of solid organ transplant patients treated with tacrolimus showed
that individuals carrying a CYP3A5*1 allele have lower dose-adjusted trough blood …
that individuals carrying a CYP3A5*1 allele have lower dose-adjusted trough blood …
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile
…, BA Oostra, H Campbell, LA Cupples, KE Davis… - Nature …, 2011 - nature.com
Genome-wide association studies have identified 32 loci influencing body mass index, but
this measure does not distinguish lean from fat mass. To identify adiposity loci, we meta-…
this measure does not distinguish lean from fat mass. To identify adiposity loci, we meta-…